Until regulatory hurdles in the EU are overcome, the US offers the greatest commercial potential and will be the primary growth market for all current and future brands indicated for fibromyalgia. Datamonitor forecasts the fibromyalgia market to more than double in value from 2008 to total $2.5 billion by 2018 across the seven major regions.
Key reasons to purchase this title
- Quantify the current and future size of the fibromyalgia market
- Assess the impact of recent and anticipated events (patent expiries, new product launches, regulatory approval) on the fibromyalgia market
- Understand the country-specific impact of key events in the fibromyalgia market during the forecast period 2009 to 2018
